MARKER THERAPEUTICS, INC. — Income Charts
2 years of history · ending 2025-12-31 · SEC EDGAR
Source:10-K · 10-Q
Revenue, Gross Profit, Operating Income & Net Income
Margin (%)
Operating Expenses
Income Breakdown
Revenue
$4M
R&D
$12M
D&A
—
Operating Income
$-13M
EBITDA
$-13M
Interest Income
$594K
Other Income/Expense
$117K
Pretax Income
$-12M
Tax Provision
$-15K
Net Income
$-12M
Operating Margin
-363.5%
Net Margin
-343.0%
Effective Tax Rate
0.1%
Deferred Tax Assets
—
DTA Valuation Allowance
$43M
Tax Credit Carryforwards
$812K
NOL Carryforwards
$41M
ETR (Continuing Operations)
0.0%
ETR Federal Statutory
21.0%
ETR State + Local (pp)
0.1%
Operating Lease Cost
—
Revenue YoY Variation
-46.2%
Income YoY Variation
-15.9%